Ligand Pharmaceuticals Appoints Jason Haas to its Board of Directors - businesswire.com -BoardProspects

Ligand Pharmaceuticals Appoints Jason Haas to its Board of Directors

businesswire.com Jun 30 2022 BoardMoves

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) (“Ligand” or “the Company”) announces the appointment of Jason Haas to the Company's Board of Directors. Mr. Haas brings more than 30 years of healthcare investment banking and corporate finance experience to Ligand...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board also categorized in BoardMoves
- Accomplished Lawyer Returns to Fulbright's Houston Office also published in businesswire.com
- TA Associates announces investment in Flashtalking also mentions Investment
- Cloud Foundry Board Elects EMC CTO As Chair also categorized in BoardMoves
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- Twitter's Jack Dorsey To Join Disney Board Of Directors also categorized in BoardMoves
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
- USA Technologies’ Board of Director Nominees Underscore Company’s Commitment to Excellence and Superior Performance also published in businesswire.com
- Airbnb Adds Outgoing American Express CEO Kenneth Chenault To Board of Directors also categorized in BoardMoves

Search:
Categories
1. BoardProspects Features:
  Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
Topics Mentioned